FindMyKOL
Clinical trialNCT01943045CompletedPhase 2Interventional

Phase 2 Study of NGM282 in Patients With Type 2 Diabetes

SponsorNGM Biopharmaceuticals, IncEnrollment81Diabetes Mellitus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the safety, tolerability, and activity of NGM282 in patients with Type 2 Diabetes.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Ngm Clinical Study Site 6103

    Melbourne, Victoria, Australia

  • Ngm Clinical Study Site 6104

    Melbourne, Victoria, Australia

  • Ngm Clinical Study Site 6101

    Perth, Western Australia, Australia

New Zealand
  • Ngm Clinical Study Site 6403

    Auckland, New Zealand

  • Ngm Clinical Study Site 6405

    Auckland, New Zealand

  • Ngm Clinical Study Site 6401

    Christchurch, New Zealand

  • Ngm Clinical Study Site 6406

    Dunedin, New Zealand

  • Ngm Clinical Study Site 6404

    Tauranga, New Zealand

  • Ngm Clinical Study Site 6402

    Wellington, New Zealand

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NGM282
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2013
Primary completion
30 Sept 2014
Completion
30 Sept 2014
Last update posted
17 Nov 2015
Registered enrollment
81
Registry id
NCT01943045

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.